Pro Health Tips
Monday, 1 April 2019
Osimertinib Combined With a New Drug Effective for Lung Cancer
Savolitinib addition to EGFR inhibitor osimertinib yielded good clinical response in patients with resistant, EGFR-mutant non-small cell lung cancer
from Medindia Health News https://ift.tt/2U8lkbn
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
Savolitinib addition to EGFR inhibitor osimertinib yielded good clinical response in patients with resistant, EGFR-mutant non-small cell lung cancer
No comments:
Post a Comment